$1.50
0[0.00%]
At close: Apr 25
$1.50
0[0.00%]
PreMarket: 4:07AM EDT
Enlivex Therapeutics
(NASDAQ:ENLV)Enlivex Therapeutics Stock (NASDAQ:ENLV), Earnings Estimates, EPS, and Revenue
Enlivex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 29
EPS
$-0.480
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Enlivex Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/29/2024 | PM | ENLV | Q4 | -$0.39 | -$0.28 | -$0.48 | -71.43% | $0.00 | — | $0.00 | — | Get Alert |
| 11/09/2023 | PM | ENLV | Q3 | -$0.31 | -$0.39 | -$0.32 | 17.95% | $0.00 | — | $0.00 | — | Get Alert |
| 09/01/2023 | PM | ENLV | Q2 | -$0.54 | -$0.46 | -$0.37 | 1956.52% | $0.00 | — | $0.00 | — | Get Alert |
| 06/16/2023 | AM | ENLV | Q1 | -$0.45 | — | -$0.39 | — | $0.00 | — | $0.00 | — | Get Alert |
| 04/10/2023 | AM | ENLV | Q4 | -$0.27 | -$0.34 | -$0.39 | -14.71% | $0.00 | — | $0.00 | — | Get Alert |
| 12/02/2022 | PM | ENLV | Q3 | -$0.19 | — | -$0.31 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/22/2022 | AM | ENLV | Q2 | -$0.17 | — | -$0.54 | — | $0.00 | — | $0.00 | — | Get Alert |
| 04/29/2022 | AM | ENLV | Q4 | — | — | -$0.27 | — | — | — | $0.00 | — | Get Alert |
| 11/22/2021 | AM | ENLV | Q3 | — | — | -$0.19 | — | — | — | $0.00 | — | Get Alert |
| 04/30/2019 | PM | ENLV | Q4 | -$0.16 | — | — | — | $0.00 | — | — | — | Get Alert |
FAQ
When is Enlivex Therapeutics (NASDAQ:ENLV) reporting earnings?
Enlivex Therapeutics (ENLV) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 29, 2024 for Q4.
What were the latest earnings per share (EPS) for Enlivex Therapeutics (NASDAQ:ENLV)?
Enlivex Therapeutics (ENLV) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 29, 2024 for Q4 and the Actual EPS was $-0.48, which missed the estimate of $-0.28.
What were Enlivex Therapeutics’s (NASDAQ:ENLV) revenues?
Enlivex Therapeutics (ENLV) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 29, 2024 for Q4 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.